β-defensin 7 Activators

β-defensin 7, commonly abbreviated as BD-7 and encoded by the gene DEFB107, is a member of the beta-defensin family of antimicrobial peptides. These small, cationic peptides are an integral component of the innate immune system, providing the first line of defense against a wide range of pathogens, including bacteria, fungi, and viruses.BD-7, like other β-defensins, is characterized by its rich content of positively charged amino acids and a specific arrangement of disulfide bridges that confer a stable β-sheet structure. The positive charge of BD-7 facilitates its interaction with the negatively charged microbial cell membranes, leading to membrane disruption and subsequent pathogen killing. The mechanism of action of BD-7 involves binding to the microbial cell membrane, forming pores that result in cell lysis and death, thus preventing infection and colonization.

Expressed primarily in the epithelial cells of the respiratory tract, BD-7 plays a significant role in pulmonary defense. Its expression can be induced by microbial components and inflammatory cytokines, signifying its involvement in both the innate and adaptive immune responses. The ability to be upregulated during infection or inflammation makes BD-7 a crucial effector molecule in the mucosal immunity of the respiratory system. Research into BD-7 has implications for understanding the molecular basis of host defense and the development of new strategies. Due to its antimicrobial properties, BD-7 and other defensins are considered promising candidates for the development of novel antimicrobial agents, especially in the face of increasing antibiotic resistance.